Bayban’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Bayban's WST Position: Q3 2026 in Review
Bayban sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 25 shares — an estimated $8.98K sold.
Bayban first reported a position in WST in Q4 2025 and held it in 3 quarters. The position peaked at $27.2K in Q4 2025. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Bayban reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Bayban sold 25 West Pharmaceutical shares in Q3 2026, an estimated $8.98K.
- Bayban first reported a position in West Pharmaceutical in Q4 2025 and held it in 3 quarters.
- Bayban's West Pharmaceutical position peaked at $27.2K in Q4 2025.
- 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.